Male bladder cancer vulnerability could be exploited to desi

Male bladder cancer vulnerability could be exploited to design new therapeutic strategies


Male bladder cancer vulnerability could be exploited to design new therapeutic strategies
A protein variant common in malignant bladder tumor cells may serve as a new avenue for treating bladder cancer. A multi-institution study led by UC Davis Comprehensive Cancer Center researchers found that targeting androgen receptors - a type of protein that is crucial for the function of testosterone - may destroy cancer cells.
The study, published in the April 28, 2021 issue of
Cancer Letters is important because, for the first time, it showed that a newly identified form of the protein is commonly expressed in bladder tumors and depleting this protein caused the cells to die.

Related Keywords

Maria Mudryj , Emily Henderson , Uc Davis Comprehensive Cancer Center , Comprehensive Cancer Center , Cancer Letters , Medicine Department , Bladder , Bladder Cancer , Dancer , Androgen , Drugs , Alignant , Medicine , Prostate , Protein , Research , Testosterone , Humor , எமிலி ஹென்டர்சன் , அக் டேவிஸ் விரிவான புற்றுநோய் மையம் , விரிவான புற்றுநோய் மையம் , புற்றுநோய் எழுத்துக்கள் , மருந்து துறை , சிறுநீர்ப்பை , விரிப்புகள் ,

© 2025 Vimarsana